Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.
Anandaiah, Asha;
Dheda, Keertan;
Keane, Joseph;
Koziel, Henry;
Moore, David AJ;
Patel, Naimish R;
(2011)
Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.
American journal of respiratory and critical care medicine, 183 (8).
pp. 987-997.
ISSN 1073-449X
DOI: https://doi.org/10.1164/rccm.201008-1246CI
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Tuberculosis (TB) disease remains one of the highest causes of mortality in HIV-infected individuals, and HIV-TB coinfection continues to grow at alarming rates, especially in sub-Saharan Africa. Surprisingly, a number of important areas regarding coinfection remain unclear. For example, increased risk of TB disease begins early in the course of HIV infection; however, the mechanism by which HIV increases this risk is not well understood. In addition, there is lack of consensus on the optimal way to diagnose latent TB infection and to manage active disease in those who are HIV infected. Furthermore, effective point-of-care testing for TB disease remains elusive. This review discusses key areas in the epidemiology, pathogenesis, diagnosis, and management of active and latent TB in those infected with HIV, focusing attention on issues related to high- and low-burden areas. Particular emphasis is placed on controversial areas where there are gaps in knowledge and on future directions of study.